Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Appoints Gene Myers to SAB; Metabolon Fleshes Out Brass; Mike Pellini Joins Safeguard Scientifics; and Others

NEW YORK (GenomeWeb News) — Helicos BioSciences has added Gene Myers to its scientific advisory board. Myers is a professor at the Janelia Farm Research Campus of the Howard Hughes Medical Institute.
 
Myers was vice president of informatics research at Celera Genomics.

Metabolon has appointed three new members to its executive team, the company said this week:
 
Tim Germann was named vice president of sales. He previously headed the sales and marketing branch of US Genomics and was involved in product launches at Affymetrix.
 
Bruce Mcreedy was named new vice president of strategic development. He was an associate vice president of infectious diseases with LabCorp and was associate vice president at Triangle Pharmaceuticals and CEO at Fulcrum
 
Dan Stevens has been named director of marketing. Stevens was formerly at Silicon Graphics and launched products at Procter and Gamble.

 
Xceed Molecular said this week it has appointed as president David Deems. He replaces Michael Cohen, who will become non-executive chairman of the board. 
 
Deems was previously vice president of development and operations at Predicant Biosciences, where he had also been vice president of development and operations. He was also vice president of product development at Exact Sciences, CEO of Union Biometrica, and was an executive at BD Biosciences.  

 
Safeguard Scientifics has added former Genomics Collaborative CEO Michael Pellini to its life sciences group as an executive in residence, the company said this week. In the position, Pellini will develop marketing opportunities, evaluate deals, and counsel the company on strategic development issues.
 
Most recently Pellini has served as COO of Lakewood Pathology Associates and was an entrepreneur in residence at BioAdvance.

 
Cepheid has renewed CEO John Bishop’s contract for four years to include a base salary of $450,000 and an annual bonus up to $225,000, the company said in a Securities and Exchange Commission filing this week.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.